摘要
目的:分析单次口服艾司佐匹克隆对健康受试者血压的影响。方法:选择18~45岁之间的健康受试者26例,随机分为1.8,3.75,7.5,11.25和15.0 mg共5个剂量组。对服药后1,4,8 h的血压进行监测和24 h,7 d随访。结果:受试者的血压在服药后呈下降趋势,服药后各时间点的血压与服药前比较差异均有显著性统计学差异(P<0.05);最大下降幅度为25 mmHg。血压降低较明显者主要集中在服药后1~4 h。11例(42.3%)受试者出现收缩压或舒张压下降>20%的情况,11.25~15 mg剂量组发生率为58.3%(7/12),高于较低剂量组的发生率(28.6%,4/14)。在11.25~15 mg剂量组,有3例血压降低>20%的受试者出现了“头晕”的不良反应。结论:应关注艾司佐匹克隆对血压的潜在影响。
Objective:To analyze the effect of single dose eszopiclone treatment on blood pressure in healthy volunteers. Methods:Twenty-six subjects were involved in the study. They were randomized into 5 subgroups with eszopiclone dosage 1.8 mg, 3.75 mg, 7.5 mg, 11.25 mg and 15.0 mg. The blood pressures were measured at 1 h,4 h, 8 h,24 h and 7 d after eszopiclone treatment. Results:The blood pressures were decreased statistically significantly ( P 〈 0.05 ). It happened at 1 h and 4 h after treatment. There were 11 subjects (42.3 % ) whose decreased rate of systolic or diastolic blood pressure were up to 20%, and the incidence in 11.25 mg - 15.0mg subgroup (58.3% ,7/12) were higher than that of in the low-dose subgroup ( 28. 6% ,4/14). Three of these subjects in 11.25 mg ~ 15.0 mg had the adverse reaction of dizziness. Conclusion : More attention should be paid to the possible effects of eszopiclone on blood pressure.
出处
《中国新药杂志》
CAS
CSCD
北大核心
2007年第11期886-889,共4页
Chinese Journal of New Drugs
关键词
艾司佐匹克隆
血压
不良反应
eszopiclone
blood pressure
adverse reaction